2nd Quarter - Report
NATIONAL ORGANIZATION FOR RARE DISORDERS, INC. (NORD) for NATIONAL ORGANIZATION FOR RARE DISORDERS INC (NORD)
Income
—
Expenses
$30,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Medicare / Medicaid issues impacting patients with rare diseases. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT New | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Health Issues HCR
Rare Disease Initiatives. Newborn Screening. Step Therapy.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT New | — |
| ALLISON HERRITY | — |
Pharmacy PHA
Pharmaceutical issues impacting patients with rare diseases. Orphan Drug Act. Inflation Reduction Act Implementation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MASON OLIVER BARRETT New | — |
| KARIN HOELZER | — |
| HEIDI ROSS | — |
Budget/Appropriations BUD
Appropriations impacting patients with rare diseases. National Institutes of Health (NIH) NCATS Appropriations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| KARIN HOELZER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.